NANueraili Aimaierjiang

Nueraili Aimaierjiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nueraili Aimaierjiang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Ainiwaer Jilili

    Department of Cardiology The First People's Hospital of Aksu Clinical Teaching Hospital of Medical School Nanjing University Aksu China

    2 shared publications
  • Xiaodong Jia

    Department of Cardiology The First People's Hospital of Aksu Clinical Teaching Hospital of Medical School Nanjing University Aksu China

    2 shared publications
  • Guoying Zhao

    International Education College Zhejiang Chinese Medical University Hangzhou China

    1 shared publication
  • Hendsun Hendsun

    Department of Cardiology Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College Hangzhou Zhejiang China

    1 shared publication
  • Hendsun Hendsun

    International Education College, Zhejiang Chinese Medical University, Hangzhou, China

    1 shared publication
  • Senhao Zhang

    Department of Cardiology The First People's Hospital of Aksu Aksu China

    1 shared publication

Latest Publications

  • Is Coffee Consumption Associated With Increased Risk of Atrial Fibrillation: A Systematic Review and a Meta‐Analysis

    by Nueraili Aimaierjiang, Hendsun Hendsun, Guoying Zhao, Xiaodong Jia, Ainiwaer Jilili, Wei Xu

    Objective: Although coffee consumption is often reported as a trigger for atrial fibrillation (AF), prospective studies on the association between coffee consumption and AF risk have been inconsistent. Hence, we sought to assess the association between coffee consumption and risk of AF. Methods: We searched PubMed, Embase, and Cochrane Library up to November 30, 2025, without language restriction. We included cohort or nested case‐control studies that enrolled participants with no AF history who did not drink coffee or had daily coffee consumption. The outcome was the risk of new‐onset AF in participants with coffee consumption. Results: Overall, 9 observational cohorts were selected for this meta‐analysis, comprising 704,121 individuals and 35,253 new‐onset AF cases. The subgroup analysis showed a reduced new‐onset AF risk among participants who drank coffee for less than or equal to 1 cup daily (RR: 0.96; 95%CI: 0.93–0.99), but no significant association with new‐onset AF risk among those who drank 1–3 cups/d (RR: 0.95; 95%CI: 0.85‐1.06), 3–5 cups/d (RR: 0.96; 95%CI: 0.91–1.02), ≥4 cups/d (RR: 0.89; 95%CI: 0.78–1.02), or ≥5 cups/d (RR: 0.93; 95%CI: 0.86–1.02). Compared with the lowest level of coffee intake, the overall estimate of the highest coffee consumption in the included studies also showed that ≥4 cups/d were not significantly associated with reduced risk of new‐onset AF (RR: 0.95; 95% CI: 0.89–1.02). In addition, this result was consistent across men (RR: 1.05; 95% CI: 0.97–1.14) and women (RR: 0.91; 95% CI: 0.80–1.04). Conclusion: Daily coffee consumption of 1 cup or less can reduce the risk of new‐onset AF. However, higher coffee consumption is not associated with the risk of new‐onset AF.

  • From Syncope to Shock: Emergency PCI Case Report in Multivessel Acute Coronary Occlusion

    by Nueraili Aimaierjiang, Hendsun Hendsun, Xiaodong Jia, Ainiwaer Jilili, Senhao Zhang, Wei Xu

    Multivessel acute total occlusion (ATO) represents an exceedingly rare and catastrophic form of acute myocardial infarction (MI), characterized by complete cessation of coronary flow in multiple epicardial vessels and profound ischemic burden. Such extensive coronary involvement often precipitates cardiogenic shock and carries exceptionally high mortality. This case report describes a 51‐year‐old male who presented with syncope and persistent chest pain following vigorous exertion. On admission, electrocardiography indicated acute anteroseptal and high lateral wall MI, and echocardiography revealed left ventricular dysfunction (LVEF 36%) with regional wall motion abnormalities. Coronary angiography demonstrated multivessel ATO involving proximal–mid left anterior descending (LAD) subtotal occlusion (TIMI 0–1), proximal left circumflex (LCx) total occlusion (TIMI 0), and mid right coronary artery (RCA) occlusion (TIMI 0). The patient developed cardiogenic shock requiring norepinephrine support. Guided by contemporary recommendations, culprit‐only percutaneous coronary intervention (PCI) of the LCx was performed via right radial access, with intracoronary administration of a glycoprotein IIb/IIIa inhibitor (Prolifiban). A 2.75 × 23 mm drug‐eluting stent was successfully implanted, achieving full reperfusion (TIMI 3) and rapid hemodynamic recovery. Subsequent staged LAD intervention was also successful. Post‐procedural outcomes were favorable, with no recurrent syncope or chest pain and improved left ventricular ejection fraction to 46% at 30 days. This case highlights the clinical complexity and therapeutic dilemma of multivessel ATO presenting with syncope and cardiogenic shock. It underscores the importance of selective culprit‐lesion revascularization, radial access, and adjunctive pharmacotherapy in achieving stabilization and favorable outcomes in this high‐risk setting.